The 18 references in paper I. Shirinsky V., O. Zheltova I., N. Solovieva Yu., V. Shirinsky S., V. Kozlov A., И. Ширинский В., О. Желтова И., Н. Соловьева Ю., В. Ширинский С., В. Козлов А. (2014) “КЛИНИЧЕСКАЯ ЭФФЕКТИВНОСТЬ СТАТИНОВ ПРИ РЕВМАТОИДНОМ АРТРИТЕ – ПИЛОТНОЕ ИССЛЕДОВАНИЕ // СLINICAL EFFICIENCY OF STATINS IN RHEUMATOID ARTHRITIS: A PILOT STUDY” / spz:neicon:mimmun:y:2007:i:5:p:505-508

1
Насонов Е.Л. Иммунологические маркеры атеросклероза // Терапевт. арх. – 2002. – No 5. – С. 57-60.
(check this in PDF content)
2
Чичасова Н.В., Насонова М.Б., Степанец О.В., Насонов Е.Л. Современные подходы к оценке активности ревматоидного артрита // Терапевт. арх. – 2002. – No 5. – С. 80-85.
(check this in PDF content)
3
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial // Lancet. – 2002. – Vol. 360. – P. 7-22.
(check this in PDF content)
4
Greenwood J., Steinman L., Zamvil S.S. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation // Nat. Rev. Immunol. – 2006. – Vol. 6. – P. 358-370.
(check this in PDF content)
5
Koopman W.J., Arthritis and allied conditions // A Textbook of Rheumatology. – Philadelphia: Lippincot Williams and Wilkins, 2001.
(check this in PDF content)
6
Leung B.P., Sattar N., Crilly A., Prach M., McCarey D.W., Payne H., Madhok R., Campbell C., Gracie J.A., Liew F.Y., McInnes I.B. A novel antiinflammatory role for simvastatin in inflammatory arthritis // J. Immunol. – 2003. – Vol. 170. – P. 1524-1530.
(check this in PDF content)
7
McCarey D.W., McInnes I.B., Madhok R., Hampson R., Scherbakov O., Ford I., Capell H.A., Sattar N. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebocontrolled trial // Lancet. – 2004. – Vol. 363. – P. 2015-2021.
(check this in PDF content)
8
McCarey D.W., Sattar N., McInnes I.B. Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? // Arthritis Res. Ther. – 2005. – Vol. 7. – P. 55-61.
(check this in PDF content)
9
Meroni P.L., Luzzana C., Ventura D. Antiinflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases? // Clin. Rev. Allergy Immunol. – 2002. – Vol. 23. – P. 263-277.
(check this in PDF content)
10
Palinski W., Napoli C. Unraveling pleiotropic effects of statins on plaque rupture // Thromb. Vasc. Biol. – 2002. – Vol. 22. – P. 1745-1750.
(check this in PDF content)
11
Seriolo B., Sulli A., Burroni A., Cutolo M. Rheumatoid arthritis and atherosclerosis // Reumatismo. – 2003. – Vol. 55. – P. 140-146.
(check this in PDF content)
12
Sever P.S., Dahlof B., Poulter N.R., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S.E., Kristinsson A., McInnes G.T., Mehlsen J., Nieminen M., O’Brien E., Ostergren J. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial // Lancet. – 2003. – Vol. 361. – P. 1149-1158.
(check this in PDF content)
13
Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlane P.W., McKillop J.H., Packard C.J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group // N. Engl. J. Med. – 1995. – Vol. 333. – P. 1301-1307.
(check this in PDF content)
14
Si M.S., Reitz B.A., Borie D.C. Inhibition of lymphocyte activation and function by the prenylation inhibitor L-778,123 // Invest. New Drugs. – 2005. – Vol. 23. – P. 21-29.
(check this in PDF content)
15
Gestel A.M., Prevoo M.L., van’t Hof M.A., van Rijswijk M.H., van de Putte L.B., van Riel P.L. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization / International League Against Rheumatism Criteria // Arthritis Rheum. – 1996. – Vol. 39. – P. 34-40.
(check this in PDF content)
16
Watson D.J., Rhodes T., Guess H.A. Allcause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis or no arthritis in the UK General Practice Research Database // J. Rheumatol. – 2003. – Vol. 30. – P. 1196-1202.
(check this in PDF content)
17
Wislowska M., Sypula S., Kowalik I. Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker’s criteria, functional index, value of Waaler-Rose titre and duration of dise ase // Clin. Rheumatol. – 1998. – Vol. 17. – P. 369-377.
(check this in PDF content)
18
Wolfe F., Freundlich B., Straus W.L. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis // J. Rheumatol. – 2003. – Vol. 30. – P. 36-40. поступила в редакцию19.02.2007
(check this in PDF content)